Table 1.

Baseline clinical characteristics of the two advanced gastric cancer patient groups before chemotherapy

Item	Number of patients	Experimental group	Control group	P
Gender	120	60	60
Male	85	42	43	1
Female	35	18	17
Age
≤ 35	28	13	15	0.829
36 to 70	92	47	45
Phase
III C	42	22	20	0.848
IV	78	38	40
Tumor location
Proximal stomach	28	15	13	1
Gastric body	40	18	22
Distal stomach	52	27	25
ECOG score
0 to 1	46	24	22	0.851
2	74	36	38
Pathological type
Well differentiated	16	7	9	0.8
Moderately differentiated	28	15	13
Poorly differentiated	76	38	38